Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

Clinical trial NCT03378102 · RECRUITING

Trial details

NCT number: NCT03378102
Sponsor: Mari Dallas
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation

Start date: 2019-01-04
Primary completion: 2028-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.